MoonLake Immunotherapeutics (NASDAQ: MLTX) logo

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Directory

Biotechnology ResearchZug, Switzerland51-200 Employees

MoonLake Immunotherapeutics (NASDAQ: MLTX) has about 140 employees across 2 continents, most of them in Europe. By country, the largest groups are United Kingdom Of Great Britain And Northern Ireland (37%), Portugal (31%) and Switzerland (25%). Administrative and Legal make up 39% of the profiles with a known department. MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce spans 16 departments. MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce grew 6% between January 2026 and November 2026.

Find MoonLake Immunotherapeutics (NASDAQ: MLTX) employees' phone numbers or email addresses

MoonLake Immunotherapeutics (NASDAQ: MLTX) Global Highlights

Location
Employees

Europe
140

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    53
  • Portugal
    44
  • Switzerland
    36
  • Germany
    2
  • Belgium
    2
  • France
    1
  • Ireland
    1
  • Italy
    1

North America
2

Minus sign iconPlus sign icon
  • United States Of America
    2

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Europe accounts for 97% of MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce, followed by North America (1%).

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s Leadership

  • Chief Financial Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    M. B.
    Chief Financial Officer
  • Chief Technical Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    O. D.
    Chief Technical Officer
  • Chief Medical Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    W. O. B.
    Chief Medical Officer
  • Chief Clinical Development Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    N. B.
    Chief Clinical Development Officer
  • Chief Of Staff To The Executive Board at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    M. R. A.
    Chief Of Staff To The Executive Board
  • Vice President Marketing, Market Access & Pricing at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    T. A.
    Vice President Marketing, Market Access & Pricing
  • Vice President Global Medical Affairs And Translational Research (promoted From Snr. Director) at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    E. C.
    Vice President Global Medical Affairs And Translational Research (promoted From Snr. Director)
  • Vice President Clinical Development at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    J. F. M.
    Vice President Clinical Development

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Business
  • Legal
  • Human Resources
  • Program & Project Management
  • Other
  • Biotechnology
  • Information Technology

Administrative is the largest department at 23% of profiles with a known department, up from 21% in January 2026, followed by Legal (16%, up from 14%) and Business (11%, down from 17%).

Contact profiles from MoonLake Immunotherapeutics (NASDAQ: MLTX)

Name
Title
Contact
Location
Last Update
  • Founder & Chief Executive Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    J. S. D. S.
    Founder & Chief Executive Officer
    Switzerland, Canton of Zug
    Oct 19, 2026
  • Chief Financial Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    M. B.
    Chief Financial Officer
    Switzerland, Zug
    Oct 25, 2026
  • Chief Technical Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    O. D.
    Chief Technical Officer
    Switzerland
    Oct 11, 2026
  • Co-Founder And Chief Scientific Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    K. R.
    Co-Founder And Chief Scientific Officer
    Switzerland
    Oct 22, 2026
  • Founder at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    A. P.
    Founder
    Switzerland
    Sep 07, 2026
  • Chief Medical Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    W. O. B.
    Chief Medical Officer
    Switzerland
    Sep 02, 2026
  • Chief Clinical Development Officer at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    N. B.
    Chief Clinical Development Officer
    United Kingdom
    Oct 02, 2026
  • Vice President Marketing, Market Access & Pricing at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    T. A.
    Vice President Marketing, Market Access & Pricing
    Switzerland, Zurich
    Oct 25, 2026
  • Associate Vice President, Head Of Information Technology at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    J. D.
    Associate Vice President, Head Of Information Technology
    Switzerland, Canton of Zug
    Jul 15, 2026
  • Vice President Global Medical Affairs And Translational Research (promoted From Snr. Director) at MoonLake Immunotherapeutics (NASDAQ: MLTX)
    E. C.
    Vice President Global Medical Affairs And Translational Research (promoted From Snr. Director)
    Belgium, Brussels Capital
    Oct 02, 2026

Frequently Asked Questions

What are the largest departments at MoonLake Immunotherapeutics (NASDAQ: MLTX)?

Minus sign iconPlus sign icon
Administrative is the largest department at 23% of profiles with a known department, up from 21% in January 2026, followed by Legal (16%, up from 14%) and Business (11%, down from 17%). MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce spans 16 departments.

Where are MoonLake Immunotherapeutics (NASDAQ: MLTX)'s employees located?

Minus sign iconPlus sign icon
MoonLake Immunotherapeutics (NASDAQ: MLTX) has about 140 employees across 2 continents, most of them in Europe. Europe accounts for 97% of MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce, followed by North America (1%). By country, the largest groups are United Kingdom Of Great Britain And Northern Ireland (37%), Portugal (31%) and Switzerland (25%).

How has MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce changed over the past year?

Minus sign iconPlus sign icon
MoonLake Immunotherapeutics (NASDAQ: MLTX)'s workforce grew 6% between January 2026 and November 2026. Administrative's share of profiles with a known department rose from 21% to 23%.

How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have currently?

Minus sign iconPlus sign icon
MoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 140 employees as of November 2026. These team members are located across 4 continents, including Europe, North America and Oceania.

Who are MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees and leadership?

Minus sign iconPlus sign icon

As of November 2026, MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees include:

  • Chief Financial Officer: M. B.
  • Chief Technical Officer: O. D.
  • Chief Medical Officer: W. O. B.
  • Chief Clinical Development Officer: N. B.
  • Chief Of Staff To The Executive Board: M. R. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s most common email format?

Minus sign iconPlus sign icon
MoonLake Immunotherapeutics (NASDAQ: MLTX) employees' email format typically follows the pattern of F.Last@moonlaketx.com. Trying to find reliable and up-to-date employee contact data? Find more MoonLake Immunotherapeutics (NASDAQ: MLTX) email formats with LeadIQ.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX) known for?

Minus sign iconPlus sign icon
MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021 and operates in the Biotechnology Research industry. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s company overview page for more information.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.